$12.90
3.45%
Nasdaq, Aug 22, 10:00 pm CET
ISIN
US52634L1089
Symbol
LNSR

LENSAR Inc Stock price

$12.90
-0.17 1.30% 1M
+3.59 38.56% 6M
+3.96 44.30% YTD
+8.50 193.18% 1Y
+6.99 118.27% 3Y
+3.90 43.33% 5Y
+3.90 43.33% 10Y
+3.90 43.33% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.43 3.45%

Key metrics

Basic
Market capitalization
$154.0m
Enterprise Value
$128.7m
Net debt
positive
Cash
$25.3m
Shares outstanding
11.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.7 | 2.2
EV/Sales
2.3 | 1.9
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
28.8%
Return on Equity
-165.3%
ROCE
-29.7%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$57.1m | $69.5m
EBITDA
$-12.7m | $-510.0k
EBIT
$-13.6m | $-5.1m
Net Income
$-56.6m | $-4.7m
Free Cash Flow
$-4.1m
Growth (TTM | estimate)
Revenue
28.3% | 30.0%
EBITDA
-31.8% | 91.5%
EBIT
-26.9% | 26.5%
Net Income
-361.6% | 85.1%
Free Cash Flow
52.4%
Margin (TTM | estimate)
Gross
47.9%
EBITDA
-22.2% | -0.7%
EBIT
-23.8%
Net
-99.2% | -6.8%
Free Cash Flow
-7.1%
More
EPS
$-4.8
FCF per Share
$-0.3
Short interest
6.0%
Employees
140
Rev per Employee
$380.0k
Show more

Is LENSAR Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

LENSAR Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a LENSAR Inc forecast:

4x Hold
57%
3x Sell
43%

Analyst Opinions

7 Analysts have issued a LENSAR Inc forecast:

Hold
57%
Sell
43%

Financial data from LENSAR Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
57 57
28% 28%
100%
- Direct Costs 30 30
35% 35%
52%
27 27
22% 22%
48%
- Selling and Administrative Expenses 31 31
18% 18%
54%
- Research and Development Expense 5.42 5.42
9% 9%
9%
-13 -13
32% 32%
-22%
- Depreciation and Amortization 0.93 0.93
15% 15%
2%
EBIT (Operating Income) EBIT -14 -14
27% 27%
-24%
Net Profit -57 -57
362% 362%
-99%

In millions USD.

Don't miss a Thing! We will send you all news about LENSAR Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LENSAR Inc Stock News

Neutral
The Motley Fool
18 days ago
Lensar (LNSR) Q2 Revenue Rises 10%
Neutral
GlobeNewsWire
18 days ago
18 ALLY Robotic Cataract Laser Systems™ (“ALLY Systems”) placed in 2Q 2025 with an additional backlog of 18 ALLY Systems pending installation as of June 30, 2025
Neutral
GlobeNewsWire
about 2 months ago
ORLANDO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR's board of directors granted three newly-hired non-executive employees an aggregate of 660 restricted stock units (“RSUs”). The RSUs were granted as of July 1, 2025, as inducement for each such employee commencing employmen...
More LENSAR Inc News

Company Profile

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.

Head office United States
CEO Nicholas Curtis
Employees 140
Founded 2004
Website www.lensar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today